Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Pacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Bain Capital’s Life Sciences team led the funding round, with contributions from new investor Wellington Management.

The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.